Showing results (1351-1360 of 1,428) with videos related to
Sort By:
Pageof 143
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 29, 2014
Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012A Zeddeman, M van Gent, C J Heuvelman, et al.Nature Communications|July 10, 2024
Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cellsHannah Donnelly, Ewan Ross, Yinbo Xiao, et al.Hepatology (Baltimore, Md.)|June 17, 2022
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffnessVineesh Indira Chandran, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen, et al.The New England Journal of Medicine|March 27, 2012
Vorapaxar in the secondary prevention of atherothrombotic eventsDavid A Morrow, Eugene Braunwald, Marc P Bonaca, et al.JACC. Cardiovascular Interventions|August 25, 2012
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stentsMichael Maeng, Hans-Henrik Tilsted, Lisette Okkels Jensen, et al.Journal of the American College of Cardiology|April 6, 2016
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery DiseaseMarc P Bonaca, Deepak L Bhatt, Robert F Storey, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2025
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trialNicolaj Brejnholt Støttrup, Evald Høj Christiansen, Bent Raungaard, et al.Circulation|July 16, 2013
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrelMatthew T Roe, Shaun G Goodman, E Magnus Ohman, et al.Nature Communications|February 10, 2023
Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cellsEwan A Ross, Lesley-Anne Turner, Hannah Donnelly, et al.Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.Pageof 143